IART · Insider Trading
Integra LifeSciences Holdings
Every open-market purchase and sale reported by IART officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Chantal Veillon-Berteloot | EVP & CHRO | F | −1,455 | −$24.18K |
| 2026-07-06 | Robert T. Davis Jr. | EVP & President, TR&DT | A | +11,180 deriv. | — |
| 2026-07-06 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | F | −937 | −$16.76K |
| 2026-07-06 | Harvinder Singh | EVP & President, SS | A | +5,590 deriv. | — |
| 2026-07-06 | Lea Daniels Knight | EVP & Chief Financial Officer | F | −5,226 | −$94.33K |
| 2026-06-03 | Stuart Essig | President and CEO | A | +1,070,765 deriv. | — |
| 2026-06-03 | Michael J. McBreen | EVP & Chief Commercial Officer | A | +92,281 deriv. | — |
| 2026-05-11 | Renee Wonlai Lo | Director | A | +17,700 deriv. | — |
| 2026-05-11 | Shaundra Clay | Director | A | +17,700 deriv. | — |
| 2026-05-11 | Keith Bradley | Director | F | −882 | −$12.28K |
| 2026-05-11 | Christian S Schade | Director | A | +17,700 deriv. | — |
| 2026-05-11 | Jeffrey A Graves | Director | A | +17,700 deriv. | — |
| 2026-05-11 | Barbara B Hill | Director | A | +24,338 | — |
| 2026-03-12 | Michael Damon Hutchinson | EVP, Chief Legal Officer & Sec | A | +70,305 deriv. | — |
| 2026-03-12 | Lea Daniels Knight | EVP & Chief Financial Officer | F | −8,089 | −$77.74K |
| 2026-03-12 | Chantal Veillon-Berteloot | EVP & CHRO | F | −5,420 | −$52.09K |
| 2026-03-12 | Mojdeh Poul | President & CEO | A | +343,393 deriv. | — |
| 2026-03-12 | Robert T. Davis Jr. | EVP & President, TT | F | −9,174 | −$88.12K |
| 2026-03-12 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | F | −1,147 | −$11.00K |
| 2026-03-12 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | MIXED | +13,486 | −$63.89K |
| 2026-03-12 | Michael J. McBreen | EVP & President, CSS | F | −9,601 | −$92.12K |
| 2026-02-04 | Michael Damon Hutchinson | EVP, Chief Legal Officer & Sec | A | +89,606 deriv. | — |
| 2026-01-07 | Mojdeh Poul | President & CEO | MIXED | — | −$18.25K |
| 2025-11-06 | Jeffrey A Graves | Director | Buy | +9,000 | +$102.15K |
| 2025-10-14 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | MIXED | +8,684 | −$43.77K |
| 2025-09-02 | Chantal Veillon-Berteloot | EVP & CHRO | F | −3,551 | −$53.73K |
| 2025-08-18 | Stuart Essig | Director | J | — | — |
| 2025-07-07 | Lea Daniels Knight | EVP & Chief Financial Officer | F | −2,561 | −$34.55K |
| 2025-07-07 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | F | −3,345 | −$45.12K |
| 2025-07-02 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | F | −937 | −$12.42K |
| 2025-05-13 | Shaundra Clay | Director | A | +19,592 | — |
| 2025-05-13 | Jeffrey A Graves | Director | A | +19,592 | — |
| 2025-05-13 | Christian S Schade | Director | A | +26,531 | — |
| 2025-05-13 | Barbara B Hill | Director | A | +26,531 | — |
| 2025-05-13 | Keith Bradley | Director | MIXED | +19,200 | −$4.80K |
| 2025-05-13 | Renee Wonlai Lo | Director | A | +19,592 | — |
| 2025-05-13 | Stuart Essig | Exec. Chairman of the Board | A | +31,837 | — |
| 2025-03-13 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | MIXED | +5,071 | −$10.61K |
| 2025-03-13 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | MIXED | +11,217 | −$15.50K |
| 2025-03-13 | Robert T. Davis Jr. | EVP & President, TT | MIXED | +11,046 | −$33.03K |
| 2025-03-13 | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | MIXED | +19,204 | −$39.64K |
| 2025-03-13 | Chantal Veillon-Berteloot | EVP & CHRO | MIXED | +6,819 | −$12.55K |
| 2025-03-13 | Michael J. McBreen | EVP & President, CSS | MIXED | +16,447 | −$48.69K |
| 2025-03-13 | Eric Schwartz | EVP, Chief Legal Officer & Sec | F | −2,718 | −$65.10K |
| 2025-03-11 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | MIXED | +856 | −$7.33K |
| 2025-03-11 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | F | −277 | −$6.26K |
| 2025-03-11 | Eric Schwartz | EVP, Chief Legal Officer & Sec | F | −773 | −$17.48K |
| 2025-03-11 | Robert T. Davis Jr. | EVP & President, TT | F | −592 | −$13.39K |
| 2025-03-11 | Michael J. McBreen | EVP & President, CSS | F | −2,285 | −$51.66K |
| 2025-01-08 | Mojdeh Poul | President & CEO | A | +321,649 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Stuart Essig | President and CEO | 1,152,236 | $13.82M |
| Barbara B Hill | Director | 169,841 | $2.04M |
| Christian S Schade | Director | 90,034 | $1.08M |
| Keith Bradley | Director | 88,254 | $1.06M |
| Robert T. Davis Jr. | EVP & President, TR&DT | 74,874 | $897.74K |
| Michael J. McBreen | EVP & Chief Commercial Officer | 60,743 | $728.31K |
| Eric Schwartz | EVP, Chief Legal Officer & Sec | 56,020 | $671.68K |
| Lea Daniels Knight | EVP & Chief Financial Officer | 45,263 | $542.70K |
| Shaundra Clay | Director | 41,515 | $497.76K |
| Jeffrey A Graves | Director | 41,086 | $492.62K |
| Renee Wonlai Lo | Director | 35,743 | $428.56K |
| Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | 34,516 | $413.85K |
| Jan De Witte | President & CEO | 28,164 | $337.69K |
| Harvinder Singh | EVP & President, SS | 23,152 | $277.59K |
| Chantal Veillon-Berteloot | EVP & CHRO | 20,772 | $249.06K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IART quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.